Tenthpin opens centre for life sciences cloud solutions in Pune

Sanjiv Das
Sanjiv Das
· 4 min read
Mr. Michael Schmidt, Founder and Member of the Executive Board of Tenthpin inaugurating Center for Life Sciences Cloud Solutions in Pune in the presence of Ms. Stephanie Marx, Partner and Key Account Delivery lead, Tenthpin and Mr. Sachin Bhure, Partner and Managing Director, Tenthpin India.

The mission of this centre is to develop and deploy future-ready cloud solutions for pharmaceutical, medtech, biotech, healthcare, animal health and CDMOs to help them address the specific compliance and life science industry related nuances

Switzerland-based Tenthpin Management Consultants, a global leader in management and technology consulting for Life Sciences companies, today announced the launch of Center for Life Sciences Cloud Solutions in Pune, establishing a Global Center of Excellence dedicated to cloud and AI-driven solutions to help transform Life Sciences business.

The mission of this centre is to develop and deploy future-ready cloud solutions for pharmaceutical, medtech, biotech, healthcare, animal health and CDMOs to help them address the specific compliance and life science industry related nuances, enabling regulatory compliance, real-time insights, seamless data integration and enhanced collaboration across the global value chain. This will allow Life Sciences companies to accelerate breakthroughs and improve patient outcomes. These cloud solutions are becoming specifically relevant in the new therapies, Biotech and Advanced Therapeutic Medicinal Products, the new Internet of Medical Things (IoMT) as well as in the next generation of CDMOs.

The latest state of art facility at Baner was inaugurated by Michael Schmidt, Founder and Member of the Executive Board of Tenthpin in the presence of Stephanie Marx, Partner and Key Account Delivery lead and Sachin Bhure, Partner and Managing Director, Tenthpin India.

Speaking on the occasion, Michael Schmidt, said, “Opening of our new office in Pune marks an important milestone in Tenthpin’s global growth journey. Pune plays a pivotal role in delivering innovative, high-quality solutions for our Life Sciences clients around the world. With deep expertise in SAP Batch Release Hub (BRH), SAP Intelligent Clinical Supply Management (ICSM), and SAP Cell and Gene Treatment Orchestration (CGTO), and our own AI-powered, GxP-ready Tenthpin software solutions, this center will strengthen our ability to accelerate digital transformation in the Life Sciences industry.” He also stated, “Our team in India embodies our commitment to excellence, innovation, and partnership — ensuring that Tenthpin continues to set the global benchmark for SAP S/4HANA transformations and Life Sciences cloud solutions.”

“The expansion of our presence in India underscores Tenthpin’s strong belief in the power of Indian talent and innovation. India has proven to be a cornerstone of our global delivery model — combining exceptional expertise, technical excellence, and a deep commitment to quality,” said Stephanie Marx, Partner at Tenthpin. “With this step, we are further strengthening our capability to deliver high-value services and next-generation digital solutions to our life sciences clients worldwide.”

Tenthpin Solutions, a group company of Tenthpin is also expanding its footprint in India. The new Pune center will serve as a global hub for innovation — further enhancing next-generation cloud-based products and accelerators that help Life Sciences companies simplify complexity, ensure regulatory compliance and scale efficiently in a rapidly evolving digital ecosystem. This center will also collaborate with local research institutions, universities, and industry partners to drive advancements of Life Sciences in India.

“We also aim to help Indian Life Sciences companies to become global leaders in innovation with the help of local talent,” said Sachin Bhure, Partner and Managing Director India, Tenthpin. “Pune possesses world class talent pool and the augmentation of this talent and practitioners will help in the speed to market and innovation to great extent. We plan to expand our India footprint to double of current team in next one year, across all locations,” he added.

Jürgen Bauer, Founder and Chairman, the Executive Board of Tenthpin, says, “Establishing our new office in Pune is more than an expansion — it’s an investment in the future of Life Sciences innovation. India’s exceptional talent and deep technology expertise align perfectly with Tenthpin’s mission to redefine how global Life Sciences organizations run their businesses. Together with our teams in Bangalore and Hyderabad, our Pune team will be at the heart of co-creating intelligent, compliant, and transformative solutions for our clients worldwide. We are excited to build a center that not only delivers excellence but also fosters collaboration, creativity, and long-term value for our clients and partners.”

Read Next

India successfully validates the first indigenous HPV test for Cervical Cancer screening
News
June 13, 2026

India successfully validates the first indigenous HPV test for Cervical Cancer screening

India has achieved a significant milestone in cervical cancer prevention with the successful validation of the country’s first indigenous HPV DNA tests, which meet international standards for cervical cancer screening. Published in the International Journal of Cancer, a multicentre study involving leading Indian and international institutions found that Molbio Diagnostics Truenat HPV-HR Plus met the […]
Article by: IMT News Desk
Glenmark Launches Winlevi® in Key European Markets for the Treatment of Acne Vulgaris
News
June 12, 2026

Glenmark Launches Winlevi® in Key European Markets for the Treatment of Acne Vulgaris

Glenmark Specialty S.A. (GSSA), a wholly owned subsidiary of Glenmark Pharmaceuticals Ltd., has announced the launch of Winlevi® (clascoterone 10 mg/g cream) across key markets in Europe. This follows the grant of marketing authorization of the product for the treatment of acne vulgaris in both adults and adolescents aged 12 to <18 years (with usage in […]
Article by: IMT News Desk
Thyrocare Expands Its Presence in Prayagraj with the Launch of Its New Diagnostic Laboratory
News
June 12, 2026

Thyrocare Expands Its Presence in Prayagraj with the Launch of Its New Diagnostic Laboratory

Thyrocare Technologies Limited has announced the set-up of its new diagnostic laboratory in Prayagraj, Uttar Pradesh, in association with SecondMedic. The new laboratory is equipped with advanced testing infrastructure and supported by trained professionals, enabling timely and error-free diagnostic results. It caters to both specialised and routine testing requirements, offering support to ongoing and preventive […]
Article by: IMT News Desk
AstraZeneca Gets CDSCO Approval for Trastuzumab Deruxtecan in HER2-Positive Breast Cancer
News
June 12, 2026

AstraZeneca Gets CDSCO Approval for Trastuzumab Deruxtecan in HER2-Positive Breast Cancer

AstraZeneca Pharma India Ltd. (AZPIL) announced that the Central Drugs Standard Control Organisation (CDSCO) has approved an additional indication for Trastuzumab Deruxtecan 100 mg/5 mL vial lyophilized powder for concentrate for solution for infusion, in combination with Pertuzumab as a first-line treatment for adult patients with unresectable or metastatic HER2-positive (IHC 3+ or ISH+) breast cancer. In India, HER2-positive breast […]
Article by: IMT News Desk